Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | ELANE | P08246 | 9/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | CTSG | P08311 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PLG | P00747 | 1/20 | 0.41 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
| ▸ | CTRC | Q99895 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16865419 | 0.78 | NPSR1 (0.54) | NPSR1ELANECYP2C19CTSGF2 | |
| SCHEMBL16867608 | 0.75 | NPSR1 (0.51) | NPSR1ELANECYP2C19CTSGF2 | |
| SCHEMBL16865412 | 0.75 | SCN9A (0.53) | NPSR1ELANECYP2C19CTSGF2 | |
| SCHEMBL17716265 | 0.72 | ELANE (0.72) | NPSR1ELANECYP2C19CTSGF2 | |
| SCHEMBL16865411 | 0.72 | ELANE (0.50) | NPSR1ELANECYP2C19CTSGF2 | |
| SCHEMBL16865386 | 0.70 | ELANE (0.51) | NPSR1ELANECYP2C19CTSGF2 | |
| SCHEMBL17716286 | 0.69 | ELANE (0.59) | NPSR1ELANECYP2C19CTSGF2 | |
| SCHEMBL16865413 | 0.69 | ELANE (0.50) | NPSR1ELANECTSGF2PLG | |
| SCHEMBL16865417 | 0.68 | ELANE (0.43) | NPSR1ELANECTSGF2PLG | |
| SCHEMBL16865445 | 0.67 | ELANE (0.41) | ELANECYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150185368-A1 | OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
| US-20150185368-A1 | OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150185368-A1 | OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME, AND COMPOUND | C1R, C1S, C3AR1 | NPSR1 2710/4885ELANE 2715/4885CYP2C19 1712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.